Apolipoprotein A-I/apolipoprotein B ratio and aggression in violent and nonviolent young adult males

Journal of Psychiatric Research

Volumn 40, Issue 5, 2006, Pages 466-472

  Troisi, Alfonso ^a   D'Argenio, Alberto ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Main Military Hospital of Rome   (Italy)

Author keywords

Aggression; Apo A I apo B ratio; Apolipoprotein A I; Apolipoprotein B; Cholesterol; Young males

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGGRESSION; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; VIOLENCE;

EID: 33744513787     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2005.12.004     Document Type: Article

References (42)

1. American Heart Association. 2000 Heart and stroke statistical update (2001), American Heart Association, Dallas, TX
2. Buss A.H., and Perry M. The Aggression Questionnaire. Journal of Personality and Social Psychology 63 (1992) 452-459
3. Buydens-Branchey L., Branchey M., Hudson J., and Fergeson P. Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Research 93 (2000) 93-102
4. Buydens-Branchey L., Branchey M., McMakin D.L., and Hibbeln J.R. Polyunsaturated fatty acid status and aggression in cocaine addicts. Drug and Alcohol Dependence 71 (2003) 319-323
5. Centers for Disease Control and Prevention (CDC). Homicide and suicide rates-national violent death reporting system, six states, 2003. Morbidity and Mortality Weekly Report 54 (2005) 377-380
6. Diebold K., Michel G., Schweizer J., Diebold-Dorsam M., Fiehn W., and Kohl B. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?. Pharmacopsychiatry 31 (1998) 60-67
7. Engelberg H. Low serum cholesterol and suicide. Lancet 339 (1992) 727-729
8. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders - clinician version (SCID-CV) (1997), American Psychiatric Press, Washington (DC)
9. Gesch C.B., Hammond S.M., Hampson S.E., Eves A., and Crowder M.J. Influence of supplementary vitamins, minerals and essentially fatty acids on the antisocial behaviour of young adult prisoners. British Journal of Psychiatry 181 (2002) 22-28
10. Golomb B.A. Cholesterol and violence: is there a connection?. Annals of Internal Medicine 128 (1998) 478-487
11. Golomb B.A., Stattin H., and Mednick S. Low cholesterol and violent crime. Journal of Psychiatric Research 34 (2000) 301-309
12. Golomb B.A., Criqui M.H., White H., and Dimsdale J.E. Conceptual foundations of the UCSD Statin Study. A randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Annals of Internal Medicine 164 (2004) 153-162
13. Golomb B.A., Kane T., and Dimsdale J.E. Severe irritability associated with statin cholesterol-lowering drugs. Quarterly Journal of Medicine 97 (2004) 229-235
14. Harris J.A. A further evaluation of the Aggression Questionnaire: issues of validity and reliability. Behaviour Research and Therapy 35 (1997) 1047-1053
15. Hibbeln J.R., Umhau J.C., Linnoila M., George D.T., Ragan P.W., Shoaf S.E., et al. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biological Psychiatry 44 (1998) 243-249
16. Hillbrand M., and Spitz R.T. Cholesterol and aggression. Aggression and Violent Behaviour 4 (1999) 359-370
17. Hillbrand M., Spitz R.T., and Foster H. Serum cholesterol and aggression in hospitalized male forensic patients. Journal of Behavioral Medicine 18 (1995) 33-43
18. Hillbrand M., Waite B.M., Miller D.S., Spitz R.T., and Lingswiller V.M. Serum cholesterol concentrations and mood states in violent psychiatric patients: an experience sampling study. Journal of Behavioral Medicine 23 (2000) 519-529
19. Horsten M., Wamala S.P., Vingerhoets A., and Orth-Gomer K. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosomatic Medicine 59 (1997) 521-528
20. Kaplan J.R., Shively C.A., Fontenot B.M., and Morgan M. Demonstration of an association between dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosomatic Medicine 56 (1994) 479-484
21. Kendall M.J., and Nuttall S.L. The heart protection study: statins for all those at risk?. Journal of Clinical Pharmacy and Therapeutics 27 (2002) 1-4
22. Lindberg G., Larsson G., Setterlind S., and Rastam L. Serum lipids and mood in working men and women in Sweden. Journal of Epidemiology and Community Health 48 (1994) 360-363
23. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., and Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research 85 (1999) 275-291
24. Marcovina S.M., Albers J.J., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurement of apolipoproteins A.I and B. Clinical Chemistry 39 (1993) 773-781
25. Mufti R., Balon R., and Arfken C. Low cholesterol and violence. Psychiatric Services 49 (1998) 221-224
26. Muldoon M.F., Ryan C.M., Matthews K.A., and Manuck S.B. Serum cholesterol and intellectual performance. Psychosomatic Medicine 59 (1997) 382-387
27. New A.S., Sevin E.M., Mitropoulou V., Reynolds D., Novotny S.L., Callahan A., et al. Serum cholesterol and impulsivity in personality disorders. Psychiatry Research 85 (1999) 145-150
28. Pfohl B., Blum N., and Zimmerman M. Structured interview for DSM-IV personality disorders (1997), American Psychiatric Press, Washington (DC)
29. Pucadyil T.J., and Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochimica et Biophysica Acta 1714 (2005) 35-42
30. Schlueter V., Narring F., Munch U., and Michaud P.A. Trends in violent deaths among young people 10-24 years old, in Switzerland, 1969-1997. European Journal of Epidemiology 19 (2004) 291-297
31. Sniderman A.D. How, when, and why to use apolipoprotein B in clinical practice. American Journal of Cardiology 90 Suppl (2002) 48i-54i
32. Steegmans P., Fekkes D., Hoes A., Bak A., van der Does E., and Grobbee D. Low serum cholesterol concentration and serotonin metabolism in men [letter]. British Medical Journal 312 (1996) 221
33. Suris A., Lind L., Emmett G., Borman P.D., Kashner M., and Barratt E.S. Measures of aggressive behavior: overview of clinical and research instruments. Aggression and Violent Behavior 9 (2004) 165-227
34. Troisi A., and Marchetti M. Epidemiology. In: Hersen M., Ammerman R.T., and Sisson L.A. (Eds). Handbook of aggressive and destructive behavior in psychiatric patients (1994), Plenum Press, New York 95-112
35. Troisi A., Moles A., Panepuccia L., Lo Russo D., Palla G., and Scucchi S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Research 109 (2002) 213-219
36. Vevera J., Fisar Z., Kvasnicka T., Zdenek H., Starkova L., Ceska R., et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Research 133 (2005) 197-203
37. Walldius G., and Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine 255 (2004) 188-205
38. Walldius G., and Jungner I. Rationale for using apoliprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. European Heart Journal 26 (2005) 271-278
39. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apoliprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
40. Walldius G., Jungner I., Aastveit A.H., Holme I., Furberg C.D., and Sniderman A.D. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clinical Chemistry and Laboratory Medicine 42 (2004) 1355-1363
41. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
42. Zhang J., Muldoon M.F., McKeown R.E., and Cuffe S.P. Association of serum cholesterol and history of school suspension among school-age children and adolescents in the United States. American Journal of Epidemiology 161 7 (2005) 691-699